Organisation · Transparency Register · 53073567234-18
Vaccines Europe
EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.
In short
Vaccines Europe has 61 disclosed EU lobbying meetings from 2019-02-21 to 2026-07-10: 34 with the European Commission and 27 with Members of the European Parliament. Source: EU Transparency Register no. 53073567234-18, Commission disclosures and MEP declarations.
Does Vaccines Europe lobby on the files that affect you?
Run a free exposure scan — see where your company overlaps with this footprint, ranked across the EU corpus.
Files it’s lobbying on
The org's disclosed policy areas, ranked by number of meetings.
Health26 mtgs
Finance2 mtgs
Energy1 mtgs
A disclosed meeting is contact, not influence. Counts are of disclosed meetings only.
Declared fields of interest
Borders and security · Budget · Business and industry · Climate action · Competition · Consumers · Digital economy and society · Economy, finance and the euro · Education and training · Environment · External relations · Humanitarian aid and civil protection
At a glance
The officials and MEPs most often met, by disclosed-meeting count.
Commission officials
- Stella Kyriakides14
- Thierry Breton7
- Olivér Várhelyi2
- Dirk Van Den Steen1
- Marc Lemaitre1
Disclosed meetings
Newest first, showing the most recent 60 of 61. EC = European Commission, EP = Member of the European Parliament.
- 2026-07-10ECDirk Van Den Steen · Head of UnitVideocall - Request for meeting on immunisation budget and prevention as investment in fiscal sustainabilitysource ↗
- Biotech Actsource ↗
- Biotech Isource ↗
- Biotech Act, EU cardiovascular disease strategysource ↗
- Vaccines policysource ↗
- Immunisation as an investment in fiscal sustainabilitysource ↗
- 2026-03-19ECMarc Lemaitre · Director-GeneralNext generation of European public-private partnerships under FP10 / Horizon Europesource ↗
- Health Preparednesssource ↗
- 2026-01-15ECCarmen Laplaza Santos · Head of UnitExchange of views with private members of the Innovative Health Initiative Joint Undertaking (IHI-JU).source ↗
- 2026-01-15ECMaria Pilar Aguar Fernandez · DirectorExchange of views with private members of the Innovative Health Initiative Joint Undertaking (IHI-JU).source ↗
- advancing human and animal health through innovative vaccinessource ↗
- 2025-11-25ECMassimo Suardi · DirectorContinuing need for Member States to prioritise investments in prevention amidst current political, security and economic headwindssource ↗
- 2025-10-03ECOlga Solomon · Head of UnitThe discussion focused on simplifying Annex II to foster innovation while aligning with ICH guidelines, with ideas for legacy products to gradually transition.source ↗
- Critical Medicines Actsource ↗
- 2025-10-02ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiAll pressing portfolio topicssource ↗
- 2025-10-02ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiAll pressing portfolio topicssource ↗
- Health policysource ↗
- SANTsource ↗
- Critical Medicines Actsource ↗
- EU health policiessource ↗
- CMAsource ↗
- Vaccinessource ↗
- Role of Vaccines in Prevention of Diseasesource ↗
- European Healthcaresource ↗
- Critical Medicines Actsource ↗
- Introductory Meetingsource ↗
- 2025-06-17EPCASTILLO Laurentpharmasource ↗
- 2025-06-03ECFlorika Fink-Hooijer · Director-GeneralImmunisation return on investment for societiessource ↗
- 2025-05-27ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiContribution of Vaccines industry to European health union prioritiessource ↗
- 2025-05-27ECLaszlo Kristoffy · Cabinet of Commissioner Olivér VárhelyiContribution of Vaccines industry to European health union prioritiessource ↗
- Vaccinationsource ↗
- EU Health policysource ↗
- Follow up meeting after eventsource ↗
- Politiques d'immunisation en Europesource ↗
- EU health policysource ↗
- Politique de santé de l'Union européennesource ↗
- EU Immunisation Strategysource ↗
- Incontro conoscitivo e scambio di vedute sul mandato del Parlamento europeosource ↗
- 2020-11-06ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemicsource ↗
- 2020-09-30ECKarolina Herbout-Borczak · Cabinet of Commissioner Stella KyriakidesCall with pharmaceutical and medical device supply Chain on COVID-19source ↗
- 2020-06-29ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesCall with pharmaceutical and medical device industry associations on COVID-19source ↗
- 2020-06-29ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemicsource ↗
- 2020-05-29ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-05-15ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-05-08ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-05-08ECThierry Breton · Cabinet of Commissioner Thierry BretonVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-04-29ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-04-29ECThierry Breton · Cabinet of Commissioner Thierry BretonVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-04-23ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-04-23ECThierry Breton · Cabinet of Commissioner Thierry BretonVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-04-17ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-04-09ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-04-09ECThierry Breton · Cabinet of Commissioner Thierry BretonVideo call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-04-03ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-04-03ECThierry Breton · Cabinet of Commissioner Thierry BretonVideo call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-03-27ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-03-27ECThierry Breton · Cabinet of Commissioner Thierry BretonVideo call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-03-20ECThierry Breton · Cabinet of Commissioner Thierry BretonVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-03-20ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-03-13ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
Frequently asked
How many EU lobbying meetings has Vaccines Europe disclosed?
Vaccines Europe (EU Transparency Register no. 53073567234-18) appears in 61 disclosed meetings with EU officials and MEPs between 2019-02-21 and 2026-07-10: 34 with the European Commission and 27 with Members of the European Parliament.
What does Vaccines Europe lobby on?
Vaccines Europe's disclosed EU meetings most often concern Health, Finance, Energy. Every meeting and its topic is listed with its official source on this page.
Who does Vaccines Europe meet in Brussels?
Across its disclosed meetings, Vaccines Europe has met Commission officials including Stella Kyriakides, Thierry Breton, Olivér Várhelyi, and MEPs including KULJA András Tivadar, HADJIPANTELA Michalis, CLERGEAU Christophe. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
EU Transparency Register · no. 53073567234-18 ↗European Commission meeting disclosures ↗European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Related on the graph
The same footprint, mapped onto the topics and files it touches.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.
See your company’s overlap with Vaccines Europe — and the rest of the corpus.
Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.